170 related articles for article (PubMed ID: 21304009)
21. Prostate cancer in patients from rural and suburban areas--PSA value, Gleason score and presence of metastases in bone scan.
Szot W; Kostkiewicz M; Zając J; Owoc A; Bojar I
Ann Agric Environ Med; 2014; 21(4):888-92. PubMed ID: 25528940
[TBL] [Abstract][Full Text] [Related]
22. Correlation between low Gleason score and prostate specific antigen levels with incidence of bone metastases in prostate cancer patients: when to omit bone scans?
Sanjaya IP; Mochtar CA; Umbas R
Asian Pac J Cancer Prev; 2013; 14(9):4973-6. PubMed ID: 24175761
[TBL] [Abstract][Full Text] [Related]
23. Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?
Lee SH; Chung MS; Park KK; Yom CD; Lee DH; Chung BH
World J Urol; 2012 Apr; 30(2):265-9. PubMed ID: 21779835
[TBL] [Abstract][Full Text] [Related]
24. Prostate-specific antigen, Gleason sum and clinical T stage for predicting the need for radionuclide bone scan for prostate cancer patients in Japan.
Ishizuka O; Tanabe T; Nakayama T; Kawakami M; Kinebuchi Y; Nishizawa O
Int J Urol; 2005 Aug; 12(8):728-32. PubMed ID: 16174046
[TBL] [Abstract][Full Text] [Related]
25. Role of serum prostate-specific antigen as predictor for bone metastases in newly diagnosed prostate cancer.
Singh OP; Yogi V; Redhu P; Ghori HU; Pareek A; Lal N
J Cancer Res Ther; 2019 Mar; 15(Supplement):S39-S41. PubMed ID: 30900618
[TBL] [Abstract][Full Text] [Related]
26. Is bone scintigraphy necessary in initial staging of prostate cancer patients?
Jaukovic L; Adjinovic B; Cerovic S; Joksimovic M; Soldatovic Z
Hell J Nucl Med; 2011; 14(2):126-30. PubMed ID: 21761013
[TBL] [Abstract][Full Text] [Related]
27. [The indication of bone scan for patients with newly diagnosed prostate cancer].
Liu D; Wang W; Qiao LD; Zheng YP; Liu YX; Zhang GY; Chen S
Zhonghua Wai Ke Za Zhi; 2012 May; 50(5):443-5. PubMed ID: 22883953
[TBL] [Abstract][Full Text] [Related]
28. Which patients with newly diagnosed prostate cancer need a computed tomography scan of the abdomen and pelvis? An analysis based on 588 patients.
Lee N; Newhouse JH; Olsson CA; Benson MC; Petrylak DP; Schiff PB; Bagiella E; Malyszko B; Ennis RD
Urology; 1999 Sep; 54(3):490-4. PubMed ID: 10475360
[TBL] [Abstract][Full Text] [Related]
29. Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer.
Huncharek M; Muscat J
Cancer Invest; 1995; 13(1):31-5. PubMed ID: 7530590
[TBL] [Abstract][Full Text] [Related]
30. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer.
Oesterling JE; Martin SK; Bergstralh EJ; Lowe FC
JAMA; 1993 Jan; 269(1):57-60. PubMed ID: 7677962
[TBL] [Abstract][Full Text] [Related]
31. [The criteria for avoiding unnecessary computerized tomography and bone scan in staging patients with newly diagnosed prostate cancer: retrospective study of patients at Matsusaka Chuo General Hospital].
Matsumura Y; Otani T; Yoneda T; Matsumoto Y; Maruyama Y; Fujimoto K; Hirao Y
Nihon Hinyokika Gakkai Zasshi; 2007 Sep; 98(6):764-9. PubMed ID: 17929458
[TBL] [Abstract][Full Text] [Related]
32. Using prostate-specific antigen to eliminate the staging radionuclide bone scan.
Lee CT; Oesterling JE
Urol Clin North Am; 1997 May; 24(2):389-94. PubMed ID: 9126236
[TBL] [Abstract][Full Text] [Related]
33. When is a bone scan study appropriate in asymptomatic men diagnosed with prostate cancer?
Pal RP; Thiruudaian T; Khan MA
Asian J Androl; 2008 Nov; 10(6):890-5. PubMed ID: 18958353
[TBL] [Abstract][Full Text] [Related]
34. Should bone scan be performed in Chinese prostate cancer patients at the time of diagnosis?
Wang Y; Guo J; Xu L; Zhao N; Xu Z; Wang H; Zhu Y; Jiang S; Yang N; Yang Y; Wang G
Urol Int; 2013; 91(2):160-4. PubMed ID: 23548369
[TBL] [Abstract][Full Text] [Related]
35. [When should we perform a bone scintigraphy in patients with new diagnosis of asymptomatic prostate cancer in order to detect bone metastasis?].
Márquez-López J; Gómez-Gómez E; Anaya-Henares F; Robles-Casilda R; Requena-Tapia MJ
Arch Esp Urol; 2015 Mar; 68(2):135-41. PubMed ID: 25774820
[TBL] [Abstract][Full Text] [Related]
36. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer.
Spencer JA; Chng WJ; Hudson E; Boon AP; Whelan P
Br J Radiol; 1998 Nov; 71(851):1130-5. PubMed ID: 10434906
[TBL] [Abstract][Full Text] [Related]
37. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
38. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.
Chybowski FM; Keller JJ; Bergstralh EJ; Oesterling JE
J Urol; 1991 Feb; 145(2):313-8. PubMed ID: 1703240
[TBL] [Abstract][Full Text] [Related]
39. Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort.
Palvolgyi R; Daskivich TJ; Chamie K; Kwan L; Litwin MS
Urology; 2011 Jun; 77(6):1330-6. PubMed ID: 21492911
[TBL] [Abstract][Full Text] [Related]
40. Bone Scan Index Is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Newly Diagnosed Prostate Cancer: A Prospective Study.
Zacho HD; Gade M; Mortensen JC; Bertelsen H; Boldsen SK; Barsi T; Petersen LJ
Urology; 2017 Oct; 108():135-141. PubMed ID: 28760556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]